발행물

전체 논문

283

61

Immunogenicity and safety of a live herpes zoster vaccine in hematopoietic stem cell transplant recipients
오명돈, 윤성수, 김인호, 박완범, 김남중, 홍준식, Chun, JY, Kim, K, Lee, MK, Kang, CK, Koh, Y, Shin, DY, Choe, PG
BMC INFECTIOUS DISEASES, 202101

62

Stereotypic neutralizing V-H antibodies against SARS-CoV-2 spike protein receptor binding domain in patients with COVID-19 and healthy individuals
오명돈, 정준호, 김의석, 권성훈, 김홍빈, 박완범, 김남중, 최평균, 송경호, 성문우, 정종탁, 유덕균, 노진성, 이용희, 이현호, 강창경, Younggeun Choi, 김수정, 김상일
SCIENCE TRANSLATIONAL MEDICINE, 202101

63

A therapeutic neutralizing antibody targeting receptor binding domain of SARS-CoV-2 spike protein
Kim, C, An, Y, Lee, JN, Kwon, KS, Lee, JY, Lee, H, Yang, JS, Kim, KC, Kim, SS, Woo, HM, Kim, JW, Park, MS, Yu, KM, Kim, SM, Seo, JM, Kim, YG, Jeong, JH, Kim, M, Kim, JI, Kim, P, Bae, JS, Shim, EY, Lee, MS, Kim, MS, Noh, H, Park, GS, Park, JS, Son, D, Kim, YI, 박완범, Ryu, DK, Lee, J
NATURE COMMUNICATIONS, 202101

64

Waning Antibody Responses in Asymptomatic and Symptomatic SARS-CoV-2 Infection
Choe, PG, Kang, CK, 박완범, Suh, HJ, Jung, J, Song, KH, Bang, JH, Kim, ES, Kim, HB, Park, SW, Kim, NJ, Oh, MD
EMERGING INFECTIOUS DISEASES, 202101

65

Communication: Comparison of Respiratory Specimens for the Detection of SARS-CoV-2
박완범, Kim, NJ, Oh, MD, Kim, TS, Park, SS, Seong, MW, Choe, PG, Lee, JS, Seo, MS, Gwon, TR, Cho, SI, Kim, YG, Kim, MJ, Park, JH, Kang, CK
ANNALS OF CLINICAL AND LABORATORY SCIENCE, 202101

66

Short course of voriconazole therapy as a risk factor for relapse of invasive pulmonary aspergillosis
Shin D.H., Yoo S.-J., Jun K.I., Kim H., Kang C.K., Song K.-H., Choe P.G., Park W.B., Bang J.-H., Kim E.S., Park S.W., Kim H.B., Kim N.-J., Oh M.-D.
Scientific Reports, 202012

67

Toll-like receptor 2 downregulation and cytokine dysregulation predict mortality in patients with Staphylococcus aureus bacteremia
Kim N.-H., Sung J.Y., Choi Y.J., Choi S.-J., Ahn S., Ji E., Kim M., Kim C.J., Song K.-H., Choe P.G., Park W.B., Kim E.S., Park K.U., Kim N.-J., Oh M.-D., Kim H.B.
BMC Infectious Diseases, 202012

68

Compassionate use of hzVSF-v13 in two patients with severe COVID-19
Kang C.K., Choe P.G., Park S., Kim T.S., Seong M.-W., Kim N.-J., Oh M.-D., Park W.B., Kim Y.-W.
Journal of Medical Virology, 202011

69

Cell-Mediated Immunogenicity of Influenza Vaccination in Patients With Cancer Receiving Immune Checkpoint Inhibitors
Kang C.K., Kim H.-R., Song K.-H., Keam B., Choi S.J., Choe P.G., Kim E.S., Kim N.J., Kim Y.J., Park W.B., Kim H.B., Oh M.-D.
The Journal of infectious diseases, 202011

70

Antibody Responses to SARS-CoV-2 at 8 Weeks Postinfection in Asymptomatic Patients
Choe P.G., Kang C.K., Suh H.J., Jung J., Kang E., Lee S.Y., Song K.-H., Kim H.B., Kim N.J., Park W.B., Kim E.S., Oh M.-D.
Emerging infectious diseases, 202010